Published in Diabetologia on February 01, 2002
Molecular genetics of MODY in Germany. Diabetologia (1999) 1.44
A YAC contig map of the human genome. Nature (1995) 3.15
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia (2008) 2.44
Ocular complications associated with retrobulbar injections. Ophthalmology (1988) 2.26
Exudative senile maculopathy. I. Results of argon laser treatment. Arch Ophthalmol (1973) 2.01
Acute annular outer retinopathy: report of four cases. Am J Ophthalmol (2000) 1.97
Bilateral retinal arteritis with multiple aneurysmal dilatations. Retina (1983) 1.88
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia (2005) 1.79
Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia (2006) 1.78
Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry (1987) 1.75
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes (2001) 1.70
Bread crumb-flecked retinopathy. Retina (1992) 1.59
Outpatient postoperative fluid-gas exchange after early failed vitrectomy surgery for macular hole. Ophthalmology (1997) 1.59
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]. Klin Monbl Augenheilkd (2013) 1.58
Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Diabetologia (2010) 1.55
Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia (2009) 1.55
Benign orbital neurilemoma. Sarcomatous transformation in von Recklinghausen's disease. Arch Ophthalmol (1971) 1.49
Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1978) 1.47
Central retinal vein occlusion in young adults. Surv Ophthalmol (1993) 1.44
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors. J Clin Endocrinol Metab (1995) 1.39
Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis. Semin Arthritis Rheum (2001) 1.38
Recurrent multifocal choroiditis. Ophthalmology (1986) 1.37
Surgical results in the vitreomacular traction syndrome. Ophthalmology (1994) 1.37
Central retinal vein occlusion associated with retinal arteriovenous malformation. Ophthalmology (1993) 1.36
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest (1993) 1.35
Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection? Rheumatol Int (2000) 1.24
New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet (1995) 1.24
Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology (1985) 1.23
Adult-onset foveomacular pigment epithelial dystrophy. Am J Ophthalmol (1980) 1.23
[Intravitreal bevacizumab for neovascular age-related macular degeneration]. Ophthalmologe (2006) 1.20
Ocular manifestations of preeclampsia. Am J Ophthalmol (1987) 1.19
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19
Two cases of intraocular infection with Alaria mesocercaria (Trematoda) Am J Ophthalmol (1994) 1.19
Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med (2015) 1.18
Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab (2009) 1.18
Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest (2002) 1.17
Inflammatory mass of the optic nerve head associated with systemic Bartonella henselae infection. Arch Ophthalmol (1997) 1.16
Central retinal vein occlusion in young adults (papillophlebitis). Retina (1992) 1.16
Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol (2004) 1.16
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 1.16
Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care (1996) 1.16
Impact of cereal fibre on glucose-regulating factors. Diabetologia (2005) 1.15
Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology (1989) 1.14
Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology (1997) 1.14
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab (2006) 1.13
Involutional macular thinning. A pre-macular hole condition. Ophthalmology (1986) 1.13
Sub-5 nm hard x-ray point focusing by a combined Kirkpatrick-Baez mirror and multilayer zone plate. Opt Express (2013) 1.10
Retinal toxicity secondary to intraocular gentamicin injection. Ophthalmology (1986) 1.10
Grid photocoagulation for diffuse macular edema. Retina (1985) 1.10
Idiopathic macular holes. Am J Ophthalmol (1985) 1.10
Macular edema following panretinal photocoagulation. Retina (1985) 1.10
Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology (1996) 1.09
Sclerochoroidal calcification. Arch Ophthalmol (1992) 1.09
Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int (2007) 1.09
Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab (2011) 1.09
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) (2005) 1.08
Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye (Lond) (2007) 1.08
Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye (Lond) (2008) 1.07
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study. Diabetologia (2008) 1.07
Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol (2001) 1.07
Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes (2000) 1.06
Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology (1995) 1.06
Insulin decreases human adiponectin plasma levels. Horm Metab Res (2003) 1.05
Fundus findings in Leber's hereditary optic neuroretinopathy. III. Fluorescein angiographic studies. Arch Ophthalmol (1984) 1.04
Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye (Lond) (2008) 1.03
New isoforms of multifunctional calcium/calmodulin-dependent protein kinase II. FEBS Lett (1993) 1.03
Macular edema--an overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol (1973) 1.03
Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol (2006) 1.02
Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia (1998) 1.01
Spontaneous decalcification of a choroidal osteoma. Ophthalmology (1988) 1.01
Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab (2002) 1.00
[Working conditions for young trainees and junior researchers in ophthalmology: results of a recent online questionnaire]. Ophthalmologe (2010) 1.00
New approach for measuring properties of rp-process nuclei. Phys Rev Lett (2004) 1.00
Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology (1992) 1.00
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol (2013) 0.99
Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation. Diabetologia (2000) 0.98
Elevation of blood glucose following anaesthetic treatment in C57BL/6 mice. Horm Metab Res (2004) 0.97
Adult polyglucosan body disease: a postmortem correlation study. Neurology (2003) 0.97
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia (2001) 0.96
Significance of streptozotocin induced nicotinamide-adenine-dinucleotide (NAD) degradation in mouse pancreatic islets. FEBS Lett (1973) 0.96
Diabetic microvascular complications and growth factors. Exp Clin Endocrinol Diabetes (1995) 0.96
Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol (Copenh) (1984) 0.96
[TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy]. Med Klin (Munich) (1995) 0.96
Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina (2000) 0.95
Macular geographic helicoid choroidopathy. Arch Ophthalmol (1987) 0.95
Decalcification of a choroidal osteoma. Br J Ophthalmol (1991) 0.94
Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm Metab Res (2000) 0.94
Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes (1997) 0.94
Choroidal osteoma after intraocular inflammation. Am J Ophthalmol (1983) 0.94
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? Diabetologia (2012) 0.94
Solar retinopathy from sun-gazing under the influence of LSD. Br J Ophthalmol (1973) 0.93
Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr (2010) 0.93
Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis. Clin Rheumatol (2001) 0.92
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2000) 0.92
Indocyanine green videoangiography after acute retinal pigment epithelial tears in age-related macular degeneration. Am J Ophthalmol (1997) 0.92
Effects of felted foam on plantar pressures in the treatment of neuropathic diabetic foot ulcers. Diabetes Care (2001) 0.92